UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren's Syndrome

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (8), p.2770-2775

2006

Volltextzugriff (PDF)

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

Arthritis research & therapy, 2006-01, Vol.8 (2), p.R51-R51

2006

Volltextzugriff (PDF)

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways

European journal of immunology, 2008-04, Vol.38 (4), p.1058-1064

2008

Volltextzugriff (PDF)

Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type

Journal of innate immunity, 2011-01, Vol.3 (2), p.200-207

2011

Volltextzugriff (PDF)

B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation

European journal of immunology, 2009-05, Vol.39 (5), p.1271-1279

2009

Volltextzugriff (PDF)

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome

Annals of the rheumatic diseases, 2007-03, Vol.66 (3), p.351-357

2007

Volltextzugriff (PDF)

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

Annals of the rheumatic diseases, 2007-05, Vol.66 (5), p.700-703

2007

Volltextzugriff (PDF)

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

Arthritis research & therapy, 2009-01, Vol.11 (5), p.R156-R156

2009

Volltextzugriff (PDF)

Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis

European cytokine network, 2011-06, Vol.22 (2), p.88-102

2011

Volltextzugriff (PDF)

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.790-797

2007

Volltextzugriff (PDF)

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery

Haematologica (Roma), 2007-02, Vol.92 (2), p.e20-e23

2007

Volltextzugriff (PDF)

The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome

Arthritis and rheumatism, 2009-07, Vol.60 (7), p.1991-1997

2009

Volltextzugriff (PDF)

Animal models of HLA-B27-associated diseases: new outcomes

Joint, bone, spine : revue du rhumatisme, 2006-03, Vol.73 (2), p.132-138

2006

Volltextzugriff (PDF)

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

Arthritis research & therapy, 2009-01, Vol.11 (3), p.R77-R77

2009

Volltextzugriff (PDF)

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome

Arthritis research & therapy, 2006-01, Vol.8 (1), p.R30-R30

2006

Volltextzugriff (PDF)

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjoegren's syndrome and systemic lupus erythematosus

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.790-797

2007

Volltextzugriff (PDF)

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjoegren's syndrome

Annals of the rheumatic diseases, 2007-03, Vol.66 (3), p.351-357

2007

Volltextzugriff (PDF)

Modèles animaux de spondylarthropathies liés au HLA-B27 : où en est la recherche ?

Revue du rhumatisme (Ed. française : 1993), 2006, Vol.73 (3), p.215-221

2006

Volltextzugriff (PDF)

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjoegren's syndrome

Arthritis research & therapy, 2006-01, Vol.8 (2), p.R51-R51

2006

Volltextzugriff (PDF)

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjoegren's syndrome

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (8), p.2770-2775

2006

Volltextzugriff (PDF)

Defective costimulatory function is a striking feature of antigen‐presenting cells in an HLA–B27–transgenic rat model of spondylarthropathy

Arthritis and rheumatism, 2004-05, Vol.50 (5), p.1624-1635

2004

Volltextzugriff (PDF)

Failure to confirm coxsackievirus infection in primary Sjögren's syndrome

Arthritis and rheumatism, 2006-06, Vol.54 (6), p.2026-2028

2006

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(15)
Rheumatology
(11)
Female
(10)
Middle Aged
(10)
Adult
(8)
Aged
(7)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Immunology
(6)
Male
(6)
Sjogren's Syndrome - Immunology
(5)
Aged, 80 And Over
(4)
B-Cell Activating Factor - Blood
(4)
Cells, Cultured
(4)
Reverse Transcriptase Polymerase Chain Reaction
(4)
Animals
(3)
Antibodies, Monoclonal - Therapeutic Use
(3)
Antibodies, Monoclonal, Murine-Derived
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren's Syndrome

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways

Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type

B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery

The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome

Animal models of HLA-B27-associated diseases: new outcomes

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjoegren's syndrome and systemic lupus erythematosus

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjoegren's syndrome

Modèles animaux de spondylarthropathies liés au HLA-B27 : où en est la recherche ?

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjoegren's syndrome

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjoegren's syndrome

Defective costimulatory function is a striking feature of antigen‐presenting cells in an HLA–B27–transgenic rat model of spondylarthropathy

Failure to confirm coxsackievirus infection in primary Sjögren's syndrome

Suchergebnisse filtern